Correlation Between Duopharma Biotech and K One

Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and K One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and K One into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Duopharma Biotech Bhd and K One Technology Bhd, you can compare the effects of market volatilities on Duopharma Biotech and K One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of K One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and K One.

Diversification Opportunities for Duopharma Biotech and K One

-0.14

Correlation Coefficient

Duopharma Biotech  K One

Good diversification

The 3 months correlation between Duopharma and 0111 is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and K One Technology Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on K One Technology and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with K One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of K One Technology has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and K One go up and down completely randomly.

Pair Corralation between Duopharma Biotech and K One

Assuming the 90 days trading horizon Duopharma Biotech is expected to generate 2.35 times less return on investment than K One. But when comparing it to its historical volatility, Duopharma Biotech Bhd is 2.68 times less risky than K One. It trades about 0.07 of its potential returns per unit of risk. K One Technology Bhd is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  17.00  in K One Technology Bhd on September 13, 2024 and sell it today you would earn a total of  2.00  from holding K One Technology Bhd or generate 11.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

Duopharma Biotech Bhd  vs.  K One Technology Bhd

Duopharma Biotech Bhd

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, Duopharma Biotech may actually be approaching a critical reversion point that can send shares even higher in January 2025.

K One Technology

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in K One Technology Bhd are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting basic indicators, K One disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Duopharma Biotech and K One

The main advantage of trading using opposite Duopharma Biotech and K One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, K One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in K One will offset losses from the drop in K One's long position.

The idea behind Duopharma Biotech Bhd and K One Technology Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.